This article was originally published in The Tan Sheet
Fiscal year 2004 Labor/HHS appropriations conference report may be ready for floor action before the end of October, allowing Congress to exclude Labor/HHS funding from omnibus approps package being considered for remaining bills, according to spokesman for Senate Majority Leader Bill Frist (R-Tenn.). HR 2660 would provide more than $350 bil. in discretionary authority for HHS in FY 2004. Discrepancies between House, Senate versions, including greater NIH funding in Senate bill, are to be hammered out in committee, on the floor. Agriculture approps covering FDA funding are likely to be rolled into omnibus bill...
You may also be interested in...
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
Execs On The Move: Medical Microinstruments Gets New CEO; Changes At iRhythm; Aethlon Makes A Promotion
Corindus Vascular Robotics CEO made a lateral move to Medical Microinstruments; iRhythm hires a new CEO, while the former CEO stays on as a director; Aethlon promotes a director to chief business officer; and more.